Moderate

Approach to haemolytic anaemia (investigation)

haemolysis work-up · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A structured framework for confirming haemolysis and localising the cause as immune or non-immune, inherited or acquired, intravascular or extravascular, guiding targeted testing and urgent recognition of microangiopathy.

Red flags

  • Schistocytes with thrombocytopenia (TTP/HUS - emergency)
  • Haemoglobinuria with acute kidney injury
  • Rapidly falling haemoglobin
  • Fever with haemolysis (malaria, sepsis)
  • Neurological signs with thrombocytopenia

Assessment

Differential diagnosis

  • Autoimmune haemolytic anaemia
  • Microangiopathic (TTP/HUS/DIC)
  • Hereditary membrane/enzyme defects (spherocytosis, G6PD)
  • Haemoglobinopathy (sickle, thalassaemia)
  • Mechanical (prosthetic valve)
  • Infection (malaria) or drug-induced

Investigations

  • FBC, reticulocyte count, blood film (key: schistocytes, spherocytes, bite cells)
  • LDH (raised), haptoglobin (low), unconjugated bilirubin (raised)
  • Direct antiglobulin test
  • Urinalysis for haemoglobinuria / urinary haemosiderin (intravascular)
  • G6PD assay, osmotic fragility/EMA binding, haemoglobin electrophoresis as directed
  • Blood cultures/malaria film and coagulation screen if indicated

Management

  • Confirm haemolysis: high reticulocytes, high LDH, low haptoglobin, raised unconjugated bilirubin
  • Examine the film first - schistocytes mandate urgent microangiopathy work-up
  • Check the DAT: positive implies immune haemolysis; negative points to non-immune causes
  • Distinguish intravascular (haemoglobinuria, very high LDH, very low haptoglobin) from extravascular
  • If DAT negative, pursue inherited causes: membrane, enzyme, haemoglobinopathy testing
  • Consider PNH testing (flow cytometry) if DAT negative with thrombosis or cytopenias
  • Review drugs, infections and mechanical causes
  • If schistocytes with thrombocytopenia, treat as a thrombotic microangiopathy emergency until excluded
  • Direct definitive management to the identified mechanism

Drugs & doses

Folic acid 5 mg PO daily (supportive in chronic haemolysis)
No specific drug until mechanism defined; treat underlying cause

Disposition

Depends on cause; urgent haematology/critical care if microangiopathy suspected; outpatient work-up for stable chronic haemolysis.

Complications & pitfalls

  • Missed TTP leading to death if untreated
  • Pigment nephropathy from intravascular haemolysis
  • Gallstones in chronic haemolysis
  • Aplastic crisis (parvovirus) in chronic haemolytic states
  • Iron overload with repeated transfusion

Exam pearls

  • The blood film is the single most informative test in haemolysis
  • Schistocytes plus low platelets = think TTP and act fast
  • A negative DAT does not exclude immune haemolysis entirely but redirects to inherited causes
  • Low haptoglobin plus high LDH plus high reticulocytes is the classic triad
  • Urinary haemosiderin indicates chronic intravascular haemolysis

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.